Diagnostyka S.A. is a Polish company that specializes in medical diagnostic services, established in 1998. It operates over 1,100 blood collection points, 156 laboratories, and 19 imaging facilities across Poland, catering to approximately 20 million patients annually. The company provides a variety of diagnostic services, including blood tests, microbiological and genetic testing, as well as imaging services such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. In February 2025, Diagnostyka S.A. went public on the Warsaw Stock Exchange, offering shares at PLN 105 each, which valued the company at around PLN 3.54 billion. The initial offering involved the sale of 16.15 million existing shares, making up 47.83% of the company's share capital, by LX Beta S.à r.l., an entity controlled by MidEuropa III Management Limited. As of August 25, 2026, the company's market capitalization reached PLN 5.66 billion, with 33.76 million shares outstanding. Diagnostyka S.A. is headquartered at Prof. Michała Życzkowskiego 16, 31-864 Kraków, Poland.
AI-researched from public web sources, not from the exchange listing itself — may contain errors or omissions and is not a substitute for verifying independently.
DIAGNOSTYKA SPÓŁKA AKCYJNA's offering is currently approved on OTHER. DIAGNOSTYKA SPÓŁKA AKCYJNA is headquartered in Poland. It is classified under Biotech.
Other IPOs DiscoverIPO tracks that share a sector, market, or underwriter with DIAGNOSTYKA SPÓŁKA AKCYJNA.
Drop a live deal card into your own site — works in WordPress, Ghost, Notion, Webflow, and any self-hosted page that allows an <iframe>. It does not work in Substack or in an emailed newsletter — no email client, and Substack itself, supports arbitrary iframes. For those, use the share image or the attribution text below instead.
<iframe src="https://www.discoveripo.com/embed/diagnostyka-spolka-akcyjna" width="100%" height="300" style="border:0;max-width:560px" loading="lazy" title="DIAGNOSTYKA SPÓŁKA AKCYJNA — DiscoverIPO"></iframe>
Dark by default. For a light background, use https://www.discoveripo.com/embed/diagnostyka-spolka-akcyjna?theme=light as the src instead.
https://www.discoveripo.com/ipo/diagnostyka-spolka-akcyjna/opengraph-image
DIAGNOSTYKA SPÓŁKA AKCYJNA IPO details — tracked by DiscoverIPO: https://www.discoveripo.com/ipo/diagnostyka-spolka-akcyjna?utm_source=embed&utm_medium=text&utm_campaign=diagnostyka-spolka-akcyjna
Get emailed when DIAGNOSTYKA SPÓŁKA AKCYJNA's terms, price, or expected date change — no weekly noise, just this company.
DIAGNOSTYKA SPÓŁKA AKCYJNA is listing on OTHER.
Diagnostyka S.A. is a Polish company that specializes in medical diagnostic services, established in 1998. It operates over 1,100 blood collection points, 156 laboratories, and 19 imaging facilities across Poland, catering to approximately 20 million patients annually. The company provides a variety of diagnostic services, including blood tests, microbiological and genetic testing, as well as imaging services such as ultrasound, X-ray, computed tomography, and magnetic resonance imaging. In February 2025, Diagnostyka S.A. went public on the Warsaw Stock Exchange, offering shares at PLN 105 each, which valued the company at around PLN 3.54 billion. The initial offering involved the sale of 16.15 million existing shares, making up 47.83% of the company's share capital, by LX Beta S.à r.l., an entity controlled by MidEuropa III Management Limited. As of August 25, 2026, the company's market capitalization reached PLN 5.66 billion, with 33.76 million shares outstanding. Diagnostyka S.A. is headquartered at Prof. Michała Życzkowskiego 16, 31-864 Kraków, Poland.
European Securities and Markets Authority's Prospectus Regulation register — a prospectus approval date, not a confirmed listing date. Retrieved Aug 26, 2026.
View the original filing on ESMA →Not investment advice. DiscoverIPO is an informational database. Nothing here is a recommendation to buy or sell any security, and no content should be relied on as financial advice. All figures come from public filings and exchange calendars, may be incomplete or out of date, and should be verified against the original source before you act on them.
We use analytics and marketing cookies to understand traffic and improve the site. Cookie Policy